Adaptate - Ownership and Business Overview

Life ScienceCompany

Adaptate Ownership

Who owns Adaptate?

Adaptate is owned by Takeda Pharmaceutical. It was acquired on January 10, 2022.

Adaptate Business Overview

Where is Adaptate headquartered?

Adaptate is headquartered in London, United Kingdom.

What sector is Adaptate in?

Adaptate is a life science company.

When was Adaptate founded?

Adaptate was founded in 2019.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 294 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 257 by strategics.

Adaptate

Adaptate Biotherapeutics Ltd.

WestWorks, White City Place, 195 Wood Lane,
London, W12 7FQ
United Kingdom,
+02081947650
www.adaptate.com

Adaptate develops antibody-based therapeutics for the modulation of variable delta 1 (Vδ1) gamma delta (γδ) T cells. Adaptate’s γδ T cell engagers are designed to specifically modulate γδ T cell-mediated immune responses at tumor sites while sparing damage to healthy cells. Adaptate was founded in 2019 and is based in London, England.


 Subscribe to unlock this and 207,814
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.